2013 - ISBTS 2013 Symposium


This page contains exclusive content for the member of the following sections: TTS, IXA, ITA. Log in to view.

Mini-Oral Communications 2

26.363 - Radiation exposure in pediatric intestinal transplants

Presenter: AnneMarie, DeVoll-Zabrocki, , United States
Authors: AnneMarie DeVoll-Zabrocki1, Wendy Grant1, David Mercer1, Luciano Vargas1, Alan Langnas1

Radiation exposure in pediatric intestinal transplants

AnneMarie DeVoll-Zabrocki1, Wendy Grant1, David Mercer1, Luciano Vargas1, Alan Langnas1

1Organ Transplant, UNMC, Omaha, NE, United States

Intestinal transplantation has become the standard of care for patients with life threatening complications of intestinal failure.  Immediate post-operative care management of pediatric intestinal transplant recipients is challenging.  A recognized concern in pediatric patients over the last decade has been the potential risks from ionizing radiation to these small bodies in their early years of development.
Methods: Retrospective review of a prospective database of pediatric patients undergoing intestinal transplant.  Focus of review was radiation exposure in millisievert (mSv) in the first 6 weeks following initial transplant.  Demographics and outcomes were reviewed.
Results:  55 patients during a 4.5 year period were reviewed.  11 underwent isolated intestine and 44 combined liver/intestine transplant.  Mean age was 25.6 mo and most common diagnoses were NEC and gastroschisis.

 

 
Mean # CXR
Mean CXR radiation dose
Mean # CT
Mean CT radiation dose
Mean Total radiation dose
ISB
9.7
0.156mSv
0.5
6.05mSv
7.7177mSv
LSB
28.3
0.453mSv
1.2
11.495
12.133mSv
 
Patients under the age of 24 months were exposed to 1199 procedures with a mean dose of 1.068mSv, as compared to those over 24 months exposed to 352 procedures with a mean dose of 1.533mSv.  This higher exposure was due to a higher number of CT scans in the older patients. As reference, a single view chest radiography is approximately 0.016mSv.
Radiation exposure in critically ill pediatric patients can have potential long term effects on their overall health.  These data have heightened our awareness of this and we have made efforts to decrease their exposure.

 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada